title: Immune therapy of chronic myelogenous leukemia.
authors.affiliation: Center for Advanced Studies in Leukemia, 11693 San Vicente Boulevard, Suite 335, Los Angeles, CA 90049-5105, USA. robertpetergale@aol.com
authors.forename: Robert Peter
authors.initials: RP
authors.lastname: Gale
authors.forename: Mary M
authors.initials: MM
authors.lastname: Horowitz
authors.forename: Moshe
authors.initials: M
authors.lastname: Talpaz
authors.forename: David A
authors.initials: DA
authors.lastname: Scheinberg
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Molldrem
authors.forename: Zihai
authors.initials: Z
authors.lastname: Li
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
authors.forename: John M
authors.initials: JM
authors.lastname: Goldman
authors.forename: Sante
authors.initials: S
authors.lastname: Tura
mesh_terms: D016044:Fusion Proteins, bcr-abl / Q000502:physiology; D006801:Humans; D007167:Immunotherapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology* / Q000628:therapy*
chemical_list: D016044:Fusion Proteins, bcr-abl